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Helicobacter pylori positivity was assessed among 656 symptomatic children
in 2010–2017. Overall infection prevalence was 24.5% and a significantly higher rate
was detected in girls (28.5%) compared to boys (20.0%). Moreover, in children with
duodenal ulcer, H. pylori prevalence was higher (47.4%) compared with the rest
(23.9%). On the contrary, the infection was detected 1.9-fold less frequently in patients
with GERD (14.5%) compared with the other (27.0%) patients and 2.1-fold less often
in the presence of duodenogastric reflux (bile) reflux (13.0%) compared with the
absence of the reflux (27.0%). No significant difference was observed between the
younger (aged ≤7 years, 20.0%) and the older (aged 8–18 years, 25.5%) patients.
H. pylori infection rate in Bulgarian pediatric patients between 2010 and 2017 was
2.5-fold lower than that in 1996–2006. In conclusion, H. pylori infection is still an
important concern for Bulgarian children, although having decreased by about
1.8%/yearly over 21 years. This study reveals the importance of H. pylori diagnostics
even in the youngest symptomatic children and demonstrates an inverse association
between either GERD or bile reflux and H. pylori infection.
Keywords: Helicobacter pylori, infection, children, Bulgarian, peculiarities
Introduction
Helicobacter pylori infection is a common chronic infection affecting about
half of human population worldwide and is most often acquired in early childhood
[1, 2]. Among children, prevalence of the infection widely varies from <10% in
some developed countries such as Sweden and Germany to ≥57% in other (mostly
developing) countries such as India and Bangladesh [2]. In Bulgarian children
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aged 1–3 years, the seroprevalence of the infection was 13.5% [3]. Importantly,
the infection persists lifelong if not successfully eradicated, thus carrying risks of
ulceration or malignancy [4]; therefore,H. pylori diagnostics is of high importance
to the healthcare.
The aim of this study was to evaluate H. pylori positivity in a large number
(>650) of symptomatic Bulgarian children over 8 years and to assess factors
associated with the infection.
Material and Methods
H. pylori positivity of 656 untreated symptomatic children (365 girls and
300 boys, 109 children aged ≤7 years, and 547 aged 8–18 years) was evaluated in
2010–2017. The characteristics of the pediatric patients are presented in Table I.
Biopsy sampling and strain isolation were performed as described in a
previous publication [5]. Briefly, the gastric biopsy specimens were transported in
Stuart transport medium (Liofilchem, Italy). The specimens were homogenized
with sterile needles and used for direct Gram staining with carbol fuchsine, a rapid
urease test with 10% urea and for culture on both non-selective (Mueller–Hinton
agar, Oxoid, UK, with 5% sheep blood), and selective media (Columbia agar base,
Liofilchem, with 5% sheep blood and Dent’s supplement). Plates were incubated
in microaerophilic atmosphere (CampyGen, Oxoid) at 37 °C for 3–10 days.










positive [95% CI] p value
Sex Girls 356 101 28.5 [23.9–33.3] 0.013*
Boys 300 60 20.0 [15.8–24.9]
Age 0–7 years 109 22 20.0 [13.7–28.7] 0.247
8–18 years 547 139 25.5 [21.9–29.2]
Diseases/symptomsa
Duodenal ulcer Yes 19 9 47.4 [27.3–68.3] 0.019*
No 637 152 23.9 [20.7–27.3]
GERD Yes 131 19 14.5 [9.4–21.6] 0.003*
No 525 142 27.0 [23.4–31.0]
DGR Yes 115 15 13.0 [8.0–20.5] 0.0016*
No 541 146 27.0 [23.2–30.7]
Total All 656 161 24.5
Note: CI: confidence interval; RAP: recurrent abdominal pain; DGR: duodenogastric reflux (bile reflux);
GERD: gastroesophageal reflux disease.
aDiseases/findings.
*Statistically significant difference.
256 BOYANOVA ET AL.
Acta Microbiologica et Immunologica Hungarica 66, 2019
Identification was made by Gram staining of the colonies, lack of aerobic
growth on blood agar plates, and testing for urease, oxidase, and catalase.H. pylori
positive status was defined when culture or both direct staining and rapid urease
test were positive. In our prior study in adults [6], the accuracy of culture was very
high (>95%) [7].
Written informed consent was received from the parents of the children. The
study was approved by the ethics committee of the Medical University of Sofia,
Sofia, Bulgaria.
Statistical analysis
Chi-square test and Fisher’s exact test of independence were performed to
compare variables of interest. Differences between groups were considered
statistically significant, if p values were <0.05. In addition, 95% confidence
intervals (95% CIs) of the groups were calculated.
Results
Overall frequency of H. pylori infection was 24.5% (161/656 children). The
frequency was significantly higher in girls (28.5%) compared with boys (20.0%,
p= 0.013; Table I).
The infection was 3.3-fold more common in patients with duodenal ulcer
(47.4%) compared with those with gastroesophageal reflux disease (GERD,
14.5%, p= 0.0006). On the contrary, the positivity was 2.1-fold less prevalent
in children with duodenogastric reflux (DGR, bile reflux, 13.0%, 15/115) com-
pared with those without the reflux (27.0%, 146/541, p= 0.0016).
According to the age groups, 20% (22/109) of the patients aged ≤7 years
and 25.5% (139/547, p= 0.247) of those aged 8–18 years were H. pylori-positive.
The youngest H. pylori-negative patient was aged 11 months and the youngest
H. pylori-positive child was aged 1 year 7 months. Totally, two (18.2%) of
11 patients aged ≤2 years were H. pylori-positive.
Discussion
The overall frequency (24.5%) of H. pylori infection in Bulgarian symp-
tomatic children was 1.9-fold higher than that in pediatric patients (13.0%) from
USA [8] and our neighboring country, Greece (13.2%) [9], and was 1.9-fold lower
than that in Colombian symptomatic children (47%), [10] and those (81.6%) in a
Spanish study of Aguilera-Correa et al. [11].
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Notably, the current prevalence of H. pylori infection in the Bulgarian
pediatric patients was 2.5-fold lower than that (61.7%) found in our previous
study, using the same methods, in 1996–2006 [7]. The result suggests a decline
(of about 1.8% per year) in the infection rate in the symptomatic children over
21 years. Similarly, although smaller (0.57% per year), decrease was found using
serology in asymptomatic Bulgarian adults over 18 years [12]. The decrease can
be explained by the so-called cohort phenomenon, i.e., lower acquisition of the
infection during the recent decades compared with that in 20th century as a result
of improved socioeconomic status, personal hygiene habits and facilities, national
antibiotic consumption, and increasingly common therapy of symptomatic
patients [13]. However, the problem of H. pylori infection is still very important,
given that every fifth child aged ≤7 years was positive.
In a meta-analysis, although overall sex differences in H. pylori infection
rates in children have shown male dominance [14], in 32 European studies, the
difference was not perceptible, showing an odds ratio (OR) and 95% CI of 0.95
[0.88, 1.03] [14]. In contrast, the sex difference was high in nine studies
from Africa with OR 1.27 [95% CI: 1.04, 1.54] [14]. In this study, the girls
were 1.42-fold more often H. pylori-positive compared with the boys. In a meta-
analysis [15], the male predominance of the infection has been detected only in
adult patients but not in children, possibly because of different antibiotic usage.
Indeed, the study of Smith et al. [16] revealed that women received about 67%
more antibiotic prescriptions per general practice consultation than men.
Whether H. pylori infection is positively or inversely associated with GERD
in pediatric patients is still a topic of controversy [17–19]. Almost half of the
children with duodenal ulcer were H. pylori-positive versus only 14.5% of those
with GERD, which can support the understanding about an inverse association
between H. pylori infection and GERD [1, 17]. However, it is noteworthy that
H. pylori eradication is not a cause of GERD and does not exacerbate the
disease [1]; therefore, treatment of the infection should not be avoided in this
patient group.
The association between DGR (bile reflux) and H. pylori infection also
remains a topic of controversy. Huang et al. [20] detected an inverse association in
H. pylori positivity between patients with bile reflux gastritis (35.8%) and those
with gastric cancer (73.0%), whereas Ma et al. [21] did not observe significant
association between both diseases in children. In the study of Silva et al. [22],
ursodeoxycholic acid did not influence H. pylori infection.
In this study, we found statistically significant 2.1-fold lower H. pylori
positivity in children with bile reflux compared with those without DGR. Bile
reflux has been presented as yellow discoloration of the mucosa and has been
associated with mucosal damage by bile salts and acids [20, 23]. The results
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indirectly support the observation of Huang et al. [20] about the inhibitory effect of
the bile on H. pylori.
Conclusions
Briefly, in 2010–2017, H. pylori infection rate in Bulgarian pediatric
patients showed a sharp decrease compared with that in 1996–2006, but it is
still a common infection affecting every fourth child, consulting the Department of
Pediatric Gastroenterology of the specialized University hospital. The peculiarities
of the infection in this study were the similar prevalence of infection in children
younger than 8 years and in the older patients, the higher infection rate in girls
compared with boys, and the lower prevalence in children with GERD or bile
reflux compared with the other pediatric patients. H. pylori infection in Bulgaria is
still an important issue.
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